EMD-23109

Single-particle
3.89 Å
EMD-23109
3D View Gallery
Deposition: 14/12/2020
Map released: 10/02/2021
Last modified: 06/03/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-23109

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7l1f summary report (pdf.gz) Map-7l1f FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

SARS-CoV-2 RdRp in complex with 4 Remdesivir monophosphate

EMD-23109

Single-particle
3.89 Å
EMD-23109
3D View Gallery
Deposition: 14/12/2020
Map released: 10/02/2021
Last modified: 06/03/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 RdRp complex with template:primer and four RMP
Fitted models: 7l1f

Deposition Authors: Bravo JPK , Taylor DW
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication.
Bravo JPK , Dangerfield TL, Taylor DW , Johnson KA
(2021) Mol Cell , 81 , 1548 - 1552.e4
PUBMED: 33631104
DOI: doi:10.1016/j.molcel.2021.01.035
ISSN: 1097-2765
ASTM: MOCEFL